Monte Rosa Therapeutics (GLUE) Pension (2020 - 2026)

Monte Rosa Therapeutics' Pension history runs 7 years deep, the most recent figure standing at $5.3 million for Q1 2026.

• On a quarterly basis, Pension rose 32.79% year-over-year to $5.3 million in Q1 2026; TTM through Mar 2026 was $5.3 million, a 32.79% increase from a year earlier, with the FY2025 full-year figure at $5.3 million, up 42.22% from the prior year.
• Pension steadied at $5.3 million in Q1 2026 per GLUE's latest filing, from $5.3 million in the prior quarter.
• Across five years, Pension topped out at $6.9 million in Q4 2022 and bottomed at $1.5 million in Q3 2023.
• The 5-year median for Pension is $2.7 million (2023), against an average of $3.3 million.
• Across the five-year window, Pension slumped 60.4% in 2023 and soared 94.29% in 2024, its largest moves.
• Year by year, Pension stood at $6.9 million in 2022, then slumped by 60.4% to $2.7 million in 2023, then soared by 36.45% to $3.7 million in 2024, then surged by 42.22% to $5.3 million in 2025, then declined by 0.09% to $5.3 million in 2026.
• Per Business Quant, the three latest GLUE Pension figures stand at $5.3 million (Q1 2026), $5.3 million (Q4 2025), and $4.7 million (Q3 2025).